Market approval of a drug or biologic requires a carefully planned clinical development strategy, as well as high-quality efficacy and safety data investigating the right indication, study population, and endpoints during your Phase I to Phase III clinical studies. From first-in-human studies to pivotal trials, SCRO has proven expertise with designing and conducting Phase I to Phase III clinical studies in a wide range of therapeutic areas.
Our clinical study teams have experience working with a variety of IMPs and indications, and the team includes key functions such as project management, clinical operations, monitoring, medical writing, data management, biostatistics, and safety. At SCRO, clinical development is both our expertise and passion, and we would love to partner with you to understand your specific needs and provide custom solutions that fit your journey.
Supporting your clinical studies
Proven expertise
SCRO services for Phase I to Phase III clinical studies:
